Axon reports Q1 2024 revenue of $461 million, up 34% year over year, raises outlook

 

AXON ENTERPRISE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
























THREE MONTHS ENDED




31 MAR 2024


31 DEC 2023


31 MAR 2023


Cash flows from operating activities:











Net income


$

133,218


$

57,271


$

45,139


Adjustments to reconcile net income to net cash provided by (used in) operating activities:











Gain on strategic investments and marketable securities, net



(97,419)



(521)



(15,570)


Stock-based compensation



75,115



35,130



34,350


Gain on remeasurement of previously held minority interest, net



(42,292)






Deferred income taxes



20,670



(19,691)



(9,660)


Depreciation and amortization



11,564



10,051



6,689


Bond amortization



(4,990)



(4,378)



(3,890)


Noncash lease expense



1,795



1,956



1,395


Amortization of debt issuance cost



782



798



756


Unrecognized tax benefits



544



473



855


Other noncash items



461



2,389



1,047


Change in assets and liabilities:











Accounts and notes receivable and contract assets



(51,132)



9,944



(50,431)


Inventory



(710)



(12,332)



(15,811)


Prepaid expenses and other assets



2



(37,762)



(64,348)


Accounts payable, accrued and other liabilities



(84,289)



50,961



(37,043)


Deferred revenue



20,743



45,749



50,199


Net cash provided by (used in) operating activities



(15,938)



140,038



(56,323)


Cash flows from investing activities:











Purchases of investments



(241,457)



(118,995)



(145,124)


Proceeds from call / maturity of investments



330,472



196,204



81,088


Purchases of property and equipment



(16,194)



(24,011)



(8,513)


Purchases of intangible assets





(56)



(125)


Proceeds from disposal of property and equipment



34



31




Strategic investments



(9,128)






Business acquisition, net of cash acquired



(237,771)






Net cash provided by (used in) investing activities



(174,044)



53,173



(72,674)


Cash flows from financing activities:











Net proceeds from equity offering







33,650


Proceeds from options exercised







39,181


Income and payroll tax payments for net-settled stock awards



(2,710)



(3,818)



(34,841)


Net cash provided by (used in) financing activities



(2,710)



(3,818)



37,990


Effect of exchange rate changes on cash and cash equivalents



(1,978)



3,266



779


Net increase (decrease) in cash and cash equivalents and restricted cash



(194,670)



192,659



(90,228)


Cash and cash equivalents and restricted cash, beginning of period



600,670



408,011



355,552


Cash and cash equivalents and restricted cash, end of period


$

406,000


$

600,670


$

265,324














« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise